mdlinx mdlinx

Dermatology - Clinical Pharmacology News & Articles

MDLinx.com consistently provides the most current Dermatology medical news articles and clinical articles daily, from over 2,000 peer-reviewed journals. Topics covered range from: Cosmetic Dermatology, Clinical Pharmacology, Dermatologic Surgery and Dermatopathology, just to name few. The MDLinx medical editors meticulously categorize and summarize clinical articles daily within 24 hours of publication to keep you abreast of with the most relevant medical news.

On this page you may also find bonus content specifically chosen by our Physician Senior Editor D. Scott Cunningham, MD, PhD, along with clinical pearls from the Smartest Doc, our daily quiz competition and Dermatology Physician Review.

Sign up today to learn more about upcoming Dermatology conferences, Continuing Medical Education (CME) opportunities, receive daily newsletters and more.

Your Unread Messages in Dermatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (2) Full Text Articles (50) Focus on Psoriasis
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

681 Treatment with the cancer drugs decitabine and doxorubicin induces human skin keratinocytes to express Oct4 and the OCT4 regulator mir-145 The Journal of Dermatology, April 13, 2012

682 Bevacizumab-induced alterations in vascular permeability and drug delivery: A novel approach to augment regional chemotherapy for in-transit melanoma Full Text Clinical Cancer Research, April 12, 2012    Clinical Article

683 Ustekinumab in clinical practice: response depends on dose and previous treatment Journal of the European Academy of Dermatology and Venereology, April 12, 2012    Clinical Article

684 A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates Full Text BMC Dermatology, April 12, 2012

685 Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol Skin Research and Technology, April 11, 2012    Clinical Article

686 Immunoregulatory effects of Isotretinoin in acne patients. British Journal of Dermatology, April 10, 2012    Clinical Article

687 A randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal British Journal of Dermatology, April 10, 2012    Clinical Article

688 Photodynamic Therapy for Multiple Eruptive Keratoacanthomas Associated With Vemurafenib Treatment for Metastatic Melanoma JAMA Dermatology, April 9, 2012    Clinical Article

689 Photochemical interaction of ascorbic acid with riboflavin, nicotinamide and alpha-tocopherol in cream formulations International Journal of Cosmetic Science, April 9, 2012

690 Association of Pharyngitis With Oral Antibiotic Use for the Treatment of Acne JAMA Dermatology, April 6, 2012    Clinical Article

691 Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata a large retrospective study on 142 patients with a self-controlled design Journal of the European Academy of Dermatology and Venereology, April 5, 2012    Clinical Article

692 Subacute cutaneous lupus erythematosus and its association to drugs: a population-based matched case-control study of 234 patients in Sweden British Journal of Dermatology, April 5, 2012

693 Photolocalized purpura during levofloxacin therapy Photodermatology, Photoimmunology and Photomedicine, April 3, 2012

694 A Multicenter, Double-Blind, Placebo-Controlled Trial of Autologous Fibroblast Therapy (Azficel-T) for the Treatment of Nasolabial Fold Wrinkles Dermatologic Surgery, April 2, 2012    Clinical Article

695 Evaluation of topical potassium hydroxide solution for treatment of plane warts Full Text Indian Journal of Dermatology, April 2, 2012    Clinical Article

696 Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomised, placebo-controlled trial with a re-treatment extension British Journal of Dermatology, March 30, 2012    Clinical Article

697 Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial The Journal of Dermatology, March 30, 2012    Clinical Article

698 Drug-induced hypersensitivity syndrome with human herpesvirus-6 reactivation Full Text Indian Journal of Dermatology, Venereology and Leprology , March 29, 2012

699 Marked, Homogeneous, and Early [18F]Fluorodeoxyglucose-Positron Emission Tomography Responses to Vemurafenib in BRAF-Mutant Advanced Melanoma Full Text Journal of Clinical Oncology, March 28, 2012    Clinical Article

700 Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis The Journal of Dermatology, March 27, 2012    Clinical Article

50 available pages First Previous 35 36 37 38 39 40 41 42 43 44 Next Last

Clinical Pearls in Dermatology

Highlights in Dermatology

Factors affecting treatment response in alopecia areata

As published in the Journal of European Academy of Dermatology & Venereology, measureable autoantibodies were associated with an increased extent of alopecia areata (AA). Ophiasic hair loss and nail dystrophy were associated with atopic AA, which in turn was associated with an increased risk of relapse.

Read the article summary

Chondroitinase ABC reduces keloids

As published in the Journal of Dermatology, injection of chondroitinase ABC into keloid grafted on to nude mice resulted in a significant reduction in keloid formation and elastic fiber formation.

Read the article summary

LL-37 is a biomarker of eczema severity in children

LL-37 corresponds to amino acids 134-170 in human cathelicidin, which is involved in innate immunity against cutaneous infections. Researchers at the Chinese University of Hong Kong conducted a study involving 144 children with eczema and 36 healthy children. The LL-37 levels were shown to be associated with the atopic dermatitis scores and the severity of eczema. The authors suggest that LL-37 is a biomarker of eczema severity in children and that innate immunity underlies the pathogenesis of eczema.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Dermatology Articles

Last month's top read Top Articles of 2012

1 Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study Journal of the European Academy of Dermatology and Venereology, April 29, 2013

2 Effective treatment of uremic pruritus and acquired perforating dermatosis with amitriptyline Australasian Journal of Dermatology, February 22, 2013

3 A randomized, double-blind, placebo and active-controlled, half-head study to evaluate the effects of platelet rich plasma on alopecia areata British Journal of Dermatology, April 23, 2013

4 Amiodarone and the risk of cancer Cancer, April 18, 2013

5 Novel Targets in the Treatment of Advanced Melanoma: New First-Line Treatment Options Annals of Pharmacotherapy, April 9, 2013

6 Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses JAMA Dermatology, March 25, 2013

7 Serum prolidase activity in psoriasis patients Archives of Dermatological Research, April 10, 2013

8 Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion Arthritis Research & Therapy, April 19, 2013

9 A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment Indian Journal of Dermatology, April 22, 2013    Free full text

10 Pimecrolimus for psoriasis Expert Opinion on Pharmacotherapy, April 8, 2013

11 Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study Journal of Dermatological Treatment , April 4, 2013

12 Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University Journal of the American Academy of Dermatology, February 25, 2013

13 Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study Journal of Dermatological Treatment , April 5, 2013

14 Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis Clinical, Cosmetic and Investigational Dermatology, March 15, 2013    Free full text

15 Rapid relief of intertrigo-associated pruritus due to Candida albicans with isoconazole nitrate and diflucortolone valerate combination therapy Mycoses, April 12, 2013

16 Carboplatin, paclitaxel and sorafenib in advanced melanoma -what have we learned? Translational Cancer Research , April 3, 2013    Free full text

17 Topical treatments for chronic plaque psoriasis Cochrane Reviews, April 1, 2013

18 Topical Retinoids in Oral Lichen Planus Treatment: An Overview Dermatology, March 29, 2013    Review Article

19 Oxidative stress and psoriasis: the effect of antitumour necrosis factor- inhibitor treatment British Journal of Dermatology, April 26, 2013

20 Ingenol Mebutate Gel 0.015% and 0.05%: In Actinic Keratosis Drugs, February 1, 2013

Indexed Journals in Dermatology: American Journal of Clinical Dermatology, Contact Dermatitis, Dermatologic Surgerymore

Other Topics in Dermatology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close